Baptist Health Heart & Vascular Care Represented at National Lipid Association Scientific Sessions - Report - MDSpire

Baptist Health Heart & Vascular Care Represented at National Lipid Association Scientific Sessions

  • By

  • June 19, 2026

  • 1 min

Share

Clinical Report: Baptist Health Heart & Vascular Care at NLA Scientific Sessions

Overview

Baptist Health Heart & Vascular Care was represented at the National Lipid Association Scientific Sessions 2026, where Dr. Heather Johnson presented on lipid management and cardiovascular risk reduction.

Background

The National Lipid Association Scientific Sessions is a key educational meeting focused on lipid science and cardiovascular prevention.

Data Highlights

No numerical data or trial data was provided in the article.

Key Findings

  • Dr. Heather Johnson presented on lipid management at the NLA Scientific Sessions 2026.
  • The session focused on evolving evidence and strategies in cardiovascular risk reduction.
  • The NLA Scientific Sessions is recognized as a premier meeting for lipid science and cardiovascular prevention.
  • Invitations to speak at the conference are reserved for leading experts in the field.

Clinical Implications

The insights shared by Dr. Johnson were presented during the session on lipid management and cardiovascular risk reduction.

Conclusion

Baptist Health Heart & Vascular Care was represented at the NLA Scientific Sessions, highlighting its participation in discussions on lipid management.

Related Resources & Content

  1. Baptist Health South Florida, Baptist Health Heart & Vascular Care at American College of Cardiology Scientific Sessions, 2026
  2. Baptist Health South Florida, Baptist Health Heart & Vascular Care Hosts Global Cardiothoracic Surgery Leaders During ISMICS 2026, 2026
  3. Baptist Health South Florida, Updated Guidelines for Reducing Heart Disease and Stroke Risks, 2026
  4. American Heart Association, 2026 Guideline on the Management of Dyslipidemia, 2026
  5. baptist health south florida — Baptist Health Brain & Spine Care Takes Center Stage at Neuroscience Nursing Conference
  6. 2026 Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association
  7. Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen - American College of Cardiology
  8. Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial - PMC

Original Source(s)

Related Content